Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Pathogen Reduction Systems Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
5.2.2. By Application (Viruses, Fungi, Bacteria)
5.2.3. By Product (Automated, Semi-Automated)
5.2.4. By End User (Hospitals & Clinics, Ambulatory Care centers, Blood Banks, Others)
5.2.5. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
5.2.6. By Company (2022)
5.3. Market Map
5.3.1 By Type
5.3.2 By Application
5.3.3 By Product
5.3.4 By End User
5.3.5 By Region
6. North America Pathogen Reduction Systems Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
6.2.2. By Application (Viruses, Fungi, Bacteria)
6.2.3. By Product (Automated, Semi-Automated)
6.2.4. By End User (Hospitals & Clinics, Ambulatory Care centers, Blood Banks, Others)
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Pathogen Reduction Systems Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Application
6.3.1.2.3. By Product
6.3.1.2.4. By End User
6.3.2. Canada Pathogen Reduction Systems Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Application
6.3.2.2.3. By Product
6.3.2.2.4. By End User
6.3.3. Mexico Pathogen Reduction Systems Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Application
6.3.3.2.3. By Product
6.3.3.2.4. By End User
7. Europe Pathogen Reduction Systems Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
7.2.2. By Application (Viruses, Fungi, Bacteria)
7.2.3. By Product (Automated, Semi-Automated)
7.2.4. By End User (Hospitals & Clinics, Ambulatory Care centers, Blood Banks, Others)
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. France Pathogen Reduction Systems Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Application
7.3.1.2.3. By Product
7.3.1.2.4. By End User
7.3.2. Germany Pathogen Reduction Systems Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Application
7.3.2.2.3. By Product
7.3.2.2.4. By End User
7.3.3. United Kingdom Pathogen Reduction Systems Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Application
7.3.3.2.3. By Product
7.3.3.2.4. By End User
7.3.4. Italy Pathogen Reduction Systems Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Application
7.3.4.2.3. By Product
7.3.4.2.4. By End User
7.3.5. Spain Pathogen Reduction Systems Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Application
7.3.5.2.3. By Product
7.3.5.2.4. By End User
8. Asia-Pacific Pathogen Reduction Systems Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
8.2.2. By Application (Viruses, Fungi, Bacteria)
8.2.3. By Product (Automated, Semi-Automated)
8.2.4. By End User (Hospitals & Clinics, Ambulatory Care centers, Blood Banks, Others)
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Pathogen Reduction Systems Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Application
8.3.1.2.3. By Product
8.3.1.2.4. By End User
8.3.2. India Pathogen Reduction Systems Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Application
8.3.2.2.3. By Product
8.3.2.2.4. By End User
8.3.3. Japan Pathogen Reduction Systems Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Application
8.3.3.2.3. By Product
8.3.3.2.4. By End User
8.3.4. South Korea Pathogen Reduction Systems Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Application
8.3.4.2.3. By Product
8.3.4.2.4. By End User
8.3.5. Australia Pathogen Reduction Systems Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Application
8.3.5.2.3. By Product
8.3.5.2.4. By End User
9. South America Pathogen Reduction Systems Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
9.2.2. By Application (Viruses, Fungi, Bacteria)
9.2.3. By Product (Automated, Semi-Automated)
9.2.4. By End User (Hospitals & Clinics, Ambulatory Care centers, Blood Banks, Others)
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Pathogen Reduction Systems Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Application
9.3.1.2.3. By Product
9.3.1.2.4. By End User
9.3.2. Argentina Pathogen Reduction Systems Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Application
9.3.2.2.3. By Product
9.3.2.2.4. By End User
9.3.3. Colombia Pathogen Reduction Systems Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Application
9.3.3.2.3. By Product
9.3.3.2.4. By End User
10. Middle East and Africa Pathogen Reduction Systems Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
10.2.2. By Application (Viruses, Fungi, Bacteria)
10.2.3. By Product (Automated, Semi-Automated)
10.2.4. By End User (Hospitals & Clinics, Ambulatory Care centers, Blood Banks, Others)
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Pathogen Reduction Systems Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Application
10.3.1.2.3. By Product
10.3.1.2.4. By End User
10.3.2. Saudi Arabia Pathogen Reduction Systems Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Application
10.3.2.2.3. By Product
10.3.2.2.4. By End User
10.3.3. UAE Pathogen Reduction Systems Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Application
10.3.3.2.3. By Product
10.3.3.2.4. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Global Pathogen Reduction Systems Market: SWOT Analysis
14. Porter’s Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Business Overview
15.2. Product Offerings
15.3. Recent Developments
15.4. Financials (As Reported)
15.5. Key Personnel
15.6. SWOT Analysis
15.6.1 Terumo BCT, Inc.
15.6.2 Macopharma SA.
15.6.3 Cerus Corporation.
15.6.4 AngioDynamics, Inc.
15.6.5 Octapharma AG.
16. Strategic Recommendations
17. About Us & Disclaimer